Management of Friedreich Ataxia
Patients with Friedreich ataxia require systematic cardiac surveillance as the primary mortality-reducing intervention, combined with multidisciplinary rehabilitation focused on functional activities rather than impairment-based exercises.
Cardiac Management - The Life-Threatening Priority
Cardiac disease is the most life-threatening manifestation and the most frequent cause of death in Friedreich ataxia 1. The cardiac involvement manifests as left ventricular hypertrophy with fibrosis and scarring, arrhythmias, and progressive heart failure 1.
Essential Cardiac Evaluations
Baseline screening with 12-lead ECG and echocardiogram is mandatory regardless of symptoms 2, 3. The resting ECG is frequently abnormal, showing first-degree AV block, bundle-branch block, Q waves, ST-T abnormalities, or PVCs 2, 3.
Maintain a low threshold for investigating any symptoms or ECG changes to determine need for pacemaker insertion, invasive EP studies, or ICD implantation 2, 3.
Follow standard pacing/ICD guidelines as for dilated cardiomyopathies 2, 3. Progression of conduction abnormalities may be unpredictable, and sudden cardiac death is a well-recognized complication 2, 3.
Device Therapy Indications
ICD therapy is indicated for secondary prevention in patients who survived ventricular fibrillation or hemodynamically unstable VT with LVEF ≤40% 2.
For primary prevention, ICD is indicated in patients with LV dysfunction, LVEF ≤30-40%, NYHA class II or III on optimal medical therapy 2, 3.
Pacemaker implantation is reasonable for any degree of AV block (including first-degree) with or without symptoms due to unpredictable progression of AV conduction disease 2, 3.
Neurological and Functional Assessment
Initial Evaluation Components
The typical age of onset is 5-15 years, though later onset occurs 1. Severity correlates loosely with the size of the smaller of the two expanded GAA repeats 1.
Key systemic features to assess include:
- Progressive cerebellar dysfunction and ataxia 1
- Scoliosis requiring monitoring 1, 4
- Diabetes mellitus screening 1
- Impaired speech and swallowing 1
- Loss of vision and hearing 1
- Respiratory function with spirometry, maximal inspiratory/expiratory pressures, and oxygen saturation 5
Respiratory Monitoring
Respiratory dysfunction is often subclinical but significant 5. Patients exhibit reduced forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and decreased maximal respiratory pressures with a restrictive ventilatory pattern 5.
- Early and regular respiratory assessment is essential as patients are vulnerable to pulmonary infections and ventilatory failure 5.
- This dysfunction reflects both neuromuscular weakness and impaired respiratory coordination 5.
Multidisciplinary Rehabilitation Strategy
Physical and Occupational Therapy Approach
Inpatient rehabilitation of 3-4 weeks duration significantly improves motor performance and ataxia symptoms 6. The treatment should be applied within a multidisciplinary setting including physiotherapy, occupational therapy, practical manual activities, and psychological support 6.
Key rehabilitation principles:
Focus on functional activity-based goals rather than impairment-based interventions 6, 7. This approach enhances transferable skills useful in activities of daily living 6.
Use Scale for the Assessment and Rating of Ataxia (SARA) and Friedreich Ataxia Rating Scale (FARS) as primary outcome measures 6, 8. Both show significant improvement post-rehabilitation 6.
For ambulatory patients, incorporate timed walks (1-minute walk, 6-minute walk), Timed Up and Go, and Berg Balance Scale 6, 8. The 1-Minute Walk demonstrates promising sensitivity comparable to modified FARS 8.
Specific Rehabilitation Components
Education is central to intervention 4, 7:
- Explain the diagnosis using a biopsychosocial framework 4
- Discuss the autosomal recessive inheritance pattern and GAA repeat expansion mechanism 1
- Address the mitochondrial dysfunction involving frataxin and iron-sulfur cluster proteins 1
Self-management strategies should be taught and reinforced 4, 7:
- Support patients to develop internal locus of control 4
- Provide tools like interactive workbooks or therapy journals 4
- Set flexible, patient-directed goals that account for symptom remission and exacerbation patterns 4
Neuroimaging Considerations
MRI of the head without IV contrast is the preferred initial imaging modality 9. Morphologic changes (atrophy) and signal alterations primarily involve the cerebellum and brainstem 9.
- Spinal cord imaging may be considered if there are additional signs of spinal cord involvement such as motor spasticity or sensory ataxia 9.
- Spinal atrophy has been reported in Friedreich ataxia along with brain parenchyma abnormalities 9.
Peripheral Nerve Assessment
High-resolution nerve ultrasound reveals variable peripheral nerve morphology 10. Nerve enlargement of median and/or ulnar nerves in proximal segments occurs in 45% of patients, while nerve atrophy is present particularly in distal segments of ulnar and tibial nerves 10.
- This reflects complex segmental pathology beyond simple axonal degeneration 10.
- Nerve enlargement shows no significant correlation with disease severity or age of onset 10.
Surgical Considerations
For patients requiring posterior spinal fusion for scoliosis, coordinated multidisciplinary perioperative care is critical 11. Patients are at high risk for perioperative complications (88% in one series) 11.
Perioperative management specifics:
- All patients have mild-to-moderate hypertrophic cardiomyopathy with preserved systolic function 11
- Consider transesophageal echocardiography monitoring intraoperatively 11
- Baseline neuromonitoring signals may be poor, requiring wake-up tests in approximately 24% of cases 11
- Major complications include hypotension/tachycardia (29%) and rare need for ECMO support 11
Clinical Trial Outcome Measures
The Upright Stability Score (USS), a sub-score of modified FARS, shows minimal placebo response 12. In contrast, appendicular items show notable placebo responses that increase with consecutive tests, shorter testing intervals, and older ages 12.
- This makes USS particularly valuable as an independent measure in clinical trials 12.